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Background: Salvia miltiorrhiza (SM) has been used to treat 
inflammatory diseases including edema and arthritis; how-
ever, the anti-inflammatory mechanism of SM action remains 
unresolved. Methods: The effects of an ethanol extract of 
SM (ESM) on pro-inflammatory cytokines such as TNF-α, 
IL-1β, IL-6, and NO, on anti-inflammatory cytokines includ-
ing IL-4, IL-10, TGF-β, and IL-1Ra have been studied in an 
attempt to elucidate the anti-inflammatory mechanism in 
murine macrophages. Results: ESM inhibited the production 
of pro-inflammatory cytokines via down-regulation of gene 
and protein expression whereas it increased the anti-in-
flammatory cytokines. Furthermore, ESM inhibited the ex-
pression of the chemokines, RANTES and CX3CL1, as well 
as of inflammatory mediators such as TLR-4 and 11β- 
HSD1. Conclusion: These results indicated that the regu-
latory effects of ESM may be mediated though the sup-
pression of pro-inflammatory cytokines as well as the in-
duction of anti-inflammatory cytokines. Consequently, we 
speculate that ESM has therapeutic potential for inflam-
mation-associated disorders.
[Immune Network 2011;11(5):288-298]
INTRODUCTION
The immune response is regulated by a highly complex and 
intricate network of control elements. Cytokines represent the 
most  powerful  regulators  of  immunological  reactions.  They 
are direct mediators of inflammation and influence the proc-
ess  and  direction  of  many  immunological  reactions  (1). 
Overproduction of inflammatory mediators contributes to the 
pathogenesis  of  several  diseases  such  as  multiple  sclerosis, 
atherosclerosis,  rheumatoid  arthritis,  chronic  inflammation, 
and autoimmune diseases (2-4). Chemokines, a group of cy-
tokines that attracts and activates leukocytes in inflamed tis-
sue, have been associated with the pathogenesis of a number 
of  inflammatory  diseases  (5). 
　Some  cytokines  clearly  promote  inflammation  and  are 
called  pro-inflammatory  cytokines,  whereas  others  suppress 
the activity of pro-inflammatory cytokines and thus, are called 
anti-inflammatory cytokines (1). The pro-inflammatory cyto-
kines,  IL-1β,  IL-6,  and  TNF-α mediate  and  modulate  im-
mune response and healing; however, if over-expressed, they 
may  increase  the  severity  of  the  disease.  Anti-inflammatory 
cytokines, IL-1ra, TGF-β,  IL-4,  and  IL-10  often  provide  in-
sufficient control over pro-inflammatory activities resulting in 
immune-mediated  diseases.  Alternatively,  they  may  over-
compensate  and  inhibit  the  immune  response,  leaving  the 
host at risk of systemic infection (6). The functions of Th1 
and Th2 cells correlate well with their distinctive cytokines. 
Th1  cells  are  involved  in  cell-mediated  inflammatory  re-
sponses such as the activation of cytotoxic and inflammatory 
reactions. Alternatively, Th2 cells produce a variety of anti-in-
flammatory cytokines with negative immunoregulatory effects 
on cellular immunity that, at the same time, upregulate hu-
moral  immunity  (7).
　Traditionally, pharmacological options for the treatment of 
inflammatory diseases have been associated with severe side 
effects  (8).  Therefore,  many  scientists  continue  to  look  for 
less toxic efficacious compounds for the treatment of inflam-Role of Salvia miltiorrhiza for Modulation of Th2-derived Cytokines in the Resolution of Inflammation
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mation and cellular injury. Of particular interest is the identi-
fication  of  new  anti-inflammatory  agents  originating  from 
plants used in traditional medicine. For example, Salvia mil-
tiorrhiza (SM) has been commonly used in traditional herbal 
medicine to prevent and treat vascular diseases such as hy-
pertension,  arteriosclerosis,  and  inflammatory  diseases  such 
as  edema,  arthritis,  and  endangitis  (9-12).
　Several studies have shown that SM critically modulates a 
variety  of  inflammatory  processes  and  immune  functions; 
however, the molecular mechanisms involved remain to be 
delineated  (13-15).  We  hypothesize  that  ESM  exerts  sig-
nificant immunomodulatory effects through the modulation of 
cytokines.  The present  study was  undertaken to investigate 
the direct effect of ESM on cytokine and chemokine gene and 
protein  expression  in  murine  macrophages.
MATERIALS AND METHODS
Reagents
An  extract  of  50%  ethanol  Salvia  miltiorrhiza  was  obtained 
from  Chungbuk  National  University.  Lipopolysaccharide 
(LPS), and 3-(4,5-dimethylthiazol-2-yl)2,5-dephenyltetrazolium 
bromide (MTT) were purchased from Sigma (St. Louis, MO, 
USA).  Dulbecco’s  Modified  Eagle  Medium  (DMEM),  anti-
biotic-penicillin/streptomycin solution, and fetal bovine serum 
( H y c l o n e ,  L o g a n ,  U T ,  U S A )  w e r e  u s e d  f o r  c e l l  c u l t u r e .
Cell culture
RAW 264.7 cells, a murine macrophage cell line, was main-
tained in a 95% air, 5% CO2 atmosphere in DMEM, supple-
mented with 10% heat-inactivated fetal bovine serum (FBS), 
10,000  U/ml  penicillin,  and  10,000  U/ml  streptomycin.
Cytotoxicity assay
Cell viability was determined via a MTT reduction assay. In 
brief,  RAW  264.7  cells  were  pre-incubated  overnight  in 
24-well plates at a density of 2×10
5 cells per well, and were 
then washed with 1x PBS. Subsequently, cells were treated 
with different concentrations of ESM for 24 h and grown in 
0.5 mg/ml MTT at 37
oC for 4 h. After removing culture super-
natants,  the  resulting  dark  blue  crystals  were  dissolved  in 
DMSO (dimethyl sulfoxide). Absorbance values were read at 
560  nm  using  an  automated  VERSAmax  microplate  reader 
(Molecular Devices, Sunnyvale, CA, USA). All determinations 
were confirmed by replication in at least three independent 
experiments.
Determination of nitrite production
Nitric oxide production from LPS-stimulated RAW 264.7 cells 
was determined by measuring the amount of nitrite, a rela-
tively stable oxidation product of N O. In brief, RAW 264.7 
cells were treated with different concentrations of ESM and 
then incubated overnight in 96-well plates at a density of 2 
×10
5 cells per well. After incubation, 100μl of culture me-
dium  from  each  sample  was  mixed  with  same  volume  of 
Griess reagent (stock-I: 0.2% N-(1-naphthyl) ethylenediamine- 
H C l ,  s t o c k - I I :  2 %  s u l f a n i l a m i d e  i n  5 %  H 2PO4).  Absorbance 
values were read at 540 nm. NO concentration was calculated 
w i t h  r e f e r e n c e  t o  a  s t a n d a r d  c u r v e  o f  s o d i u m  n i t r i t e ,  g e n -
erated  using  known  concentrations.
PGE2 assay
Assessment of PGE2 synthesis was performed using a com-
mercially available PGE2 Parameter Assay kit (R&D Systems 
Inc., Minneapolis, MN). RAW 264.7 cells were treated with 
LPS (100 ng/ml) with different concentrations of ESM for 24 
h.  PGE2  synthesis  was  performed  on  the  culture  media 
through a PGE2 enzyme immunoassay using a commercially 
available kit according to the manufacturer’s instruction. The 
concentration of PGE2 was calculated according to a standard 
curve  using  its  recombinant  protein  in  the  ELISA  kit.
Cytokine assay
The levels of IL-1β, IL-6, and TNF-α in the RAW 264.7 cell 
culture medium were measured using ELISA kits (eBioscience 
Inc.,  San  Diego,  CA)  according  to  the  manufacturer’s  in-
structions. The absorbance at 450 nm was determined using 
a microplate reader (Molecular Devices, Sunnyvale, CA) and 
the concentration of each cytokine was calculated according 
to a standard curve using each of the recombinant cytokines 
i n  t h e  E L I S A  k i t s .
Isolation of total RNA and reverse transcription- 
polymerase chain reaction (RT-PCR)
Total  RNA  was  extracted  from  RAW264.7  cells  using  the 
R N e a s y  M i n i  k i t  ( Q I A G E N ,  U S A )  i n  a n  R N a s e - f r e e  e n v i -
ronment. RNA was quantified by reading the absorbance at 
260  nm  as  previously  described  (16).  The  reverse  tran-
scription of 1μg RNA was carried out using M-MLV reverse 
transcriptase (Promega, USA), oligo (dT) 16 bp primer, dNTP 
(0.5μM) and 1 U RNase inhibitor. After incubation at 65
oC 
for 5 min and 37
oC for 60 min, M-MLV reverse transcriptase 
was  inactivated  by  heating  at  70
oC  for  15  min. Role of Salvia miltiorrhiza for Modulation of Th2-derived Cytokines in the Resolution of Inflammation
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    The PCR was performed in 50 mM KCl, 10 mM Tris-HCl 
(pH  8.3), 1.5  mM MgCl2,  and  2.5  mM  dNTPs  with  5  units 
of Taq DNA polymerase and 10 pM of each primer set for 
pro-inflammatory  cytokines  including  IL-1  β,  IL-6,  TNF-α, 
and  cox-2,  anti-inflammatory  cytokines  such  as  IL-4,  IL-10, 
TGF-β, and IL-1ra, chemokines including CX3CL1, CX3CR1, 
regulated  upon  activation  normal  T-cell  expressed  and  se-
c r e t e d  ( R A N T E S ) ,  a n d  t h e  i n f l a m m a t o r y  m e d i a t o r s  s u c h  a s ,  
TLR-4 and 11β-hydroxysteroid dehydrogenase type 1 (11β- 
HSD1). The cDNA was amplified by 35 cycles of denaturing 
at  94
oC  for  45  s,  annealing  at  60∼62
oC  for  45  s,  and  ex-
tension at 72
oC for 1 min. Final extension was performed at 
72
oC  for  5  min. 
    The PCR products were electrophoresed on 1.5% agarose 
gels  and  stained  with  ethidium  bromide  (EtBr:  0.5μg/ml). 
Verification of specific gene was established by its predicted 
sizes under ultraviolet (UV) light. The primer sequences were 
a s  f o l l o w s  ( F o r w a r d  a n d  R e v e r s e ) :
  i N O S  ( 5 ’AGCTCCTCCCAGGACCACAC and 5’ACGCTGAG-
TACCTCATTGGC), COX-2 (5’AAGAAGAAAGTCATTCCTGAT-
CCC and 5’TGACTGTGGGAGGATACATCTCTC), IL-1β (5’C-
AGGATGAGGACATGACACC and 5’CTCTGCAGACTCAAATC-
CAC), IL-6 (5’GTACTCCAGAAGACCAGAGG and 5’TGCTGG-
TGACAACCACGGCC),  TNF-α(5’TTGACCTCAGCGCTGAGT-
TG  and  5’CCTGTAGCCCACGTCGTAGC),  RANTES  (5’ATCA-
TCCTCACTGCAGCCGC  and  5’CACACTTGGCGGTTCCTTCG), 
CX3CL1  (5’CTAAACCAGGACCCTGCGG  and  5’CTAGTGG-
CAAGGTGATCCC),  CX3CR1  (5’TCCTGTCCGTCTTCTACGCC 
and  5’ATTGTGGAGGCCCTCATGGC),  TLR4  (5’TGAGAAG-
TCCCTGCTGAGGC and 5’CTCCTCAGGTCCAAGTTGCC), 11β 
-HSD1 (5’CAAGGCGGGAAAGCTCATGG and 5’ GGAGGAG-
ATGACGGCAATGC),  IL-10  (5’TGGCCACACTTGAGAGCTGC 
and  5’TTCAGGGATGAAGCGGCTGG),  TGF-β  (5’GGAG-
CTGGTGAAACGGAAGC  and  5’CATAGTAGTCCGCTTCGGG-
C), and β-actin (5’GTGGGCCGCCCTAGGACCAG and 5’GG-
AGGAAGAGGATGCGGCAGT).  β- a c t i n  w a s  u s e d  a s  a n  i n-
ternal  control.
Western blot analysis 
RAW 264.7 cells were washed with phosphate-buffered saline 
(PBS) and centrifuged at 1,200 rpm for 10 min at 4
oC. Cell 
pellets were resuspended in an appropriate volume of lysis 
buffer  (50  mM  Tris-Cl,  150  mM  NaCl,  100μg/ml  phenyl-
methylsulfonyl  fluoride,  1μg/ml  aprotinin,  and  1%  Triton) 
and  incubated  overnight  at  −20
oC .  A f t e r  c e n t r i f u g a t i o n  a t  
14,000 rpm for 60 min, the supernatant was stored at −80
oC 
until further use. Protein concentrations of sample were de-
termined by BCA protein assay (Thermo Fisher Scientific Inc., 
Rockford, IL). 20μg/ml of protein from the cell lysates was 
applied to 8∼12% SDS-polyacrylamide gels and then trans-
ferred  to  nitrocellulose  membranes.  The  membranes  were 
blocked  with  5%  skim  milk  in  PBST  solution  for  1h.  They 
were then incubated with anti-IL-1β, anti-IL-6, anti-TNF-α, 
anti-i-NOS, anti-COX-2, anti-IL-4, or anti-IL-10 monoclonal an-
tibodies  for  2  h  and  washed  3  times  with  PBST.  After  in-
cubation with an alkaline phosphatase-labeled secondary an-
tibody  for  2  h,  the  bands  were  v is ua liz e d u sin g  a W e st er n 
Blot  Kit  with  an  alkaline  phosphatase  substrate  (Vector, 
Burlingame,  USA).
Flow cytometry
RAW  264.7  cells  (1×10
6  cells/ml)  were  cultured  in  6-well 
plates. The cells were treated with various concentrations of 
ESM and incubated at 37
oC for 24 h in humidified 5% CO2 
incubator under standard conditions. The cells then washed 
with  PBS  and  centrifuged  at  1,200  rpm  for  10  min  at  4
oC. 
The washed cells were blocked with staining buffer contain-
ing 10% normal mouse serum (NMS) for 20 min on ice. The 
blocked cells were then incubated with co-stimulatory mole-
cules such as ICAM-1 (CD 54), B7-1 (CD 80), and B7-2 (CD 
86) antibodies for 20 min on ice. Incubated cells were sub-
sequently washed with staining buffer 3 times and then fixed 
with 1% paraformaldehyde in PBS. The fixed cells were then 
quantified  by  flow  cytometry  (Beckman  Coulter,  Brea,  CA, 
USA).
Data analysis  
Data  have  been  expressed  as  mean±standard  deviation. 
Statistical significance between the groups was determined by 
paired  t-test  and  one-way  ANOVA  for  repeated  measures. 
Results with p＜0.05 were considered statistically significant. 
Data  were  assessed  using  SPSS  (version  15.0,  SPSS  Inc., 
Chicago,  Illinois).
RESULTS 
Effect of ESM on RAW 264.7 cell viability 
Initially, the cytotoxicity of ESM to RAW 264.7 cells was meas-
ured by MTT assay. The cell viability was not significantly al-
tered  by  ESM  at  12.5∼100μg/ml.  Based  on  these  results, 
cells were treated with ESM in the concentration range of 12.5
∼100μg/ml during follow up experiments (data not shown). Role of Salvia miltiorrhiza for Modulation of Th2-derived Cytokines in the Resolution of Inflammation
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Figure 1.  ESM inhibited NO and PGE2 production in LPS-stimulated RAW 264.7 cells. RAW 264.7 cells were treated with various concentrations
(12.5, 25, 50, 100μg/ml) in the absence or presence of LPS (100 ng/ml) overnight. Culture supernatants were then collected and NO 
concentrations were measured using Griess reagent (A). RAW 264.7 cells were treated with various concentrations in the absence or presence
of LPS for 48 h. Culture supernatants were then collected and PGE2 concentrations were measured using ELISA kits (B). RAW 264.7 cells were
incubated with ESM in the absence or presence of LPS for 24 h. Total RNA was isolated, and levels of iNOS and COX-2 mRNA were then
measured by RT-PCR (C). Cell lysates were extracted, and protein levels of COX-2 were then analyzed by Western blotting (D). Each value
represents the mean±S.D. in triplicate. 
††p＜0.01 vs. cells only based on a Student’s t-test. *p＜0.05, **p＜0.01 vs. LPS only based on a 
student’s t-test.
ESM inhibited NO and PGE2 production in LPS- 
stimulated RAW 264.7 cells
In order to determine the effect of ESM on NO production 
in LPS-stimulated RAW 264.7 cells, the cells were incubated 
with LPS (100 ng/ml) or various concentrations of ESM (12.5, 
25,  50,  100μg/ml)  for  18  h.  After  incubation,  the  super-
natants  were  collected  and  the  accumulated  nitrite  concen-
tration was measured using Griess reagent. Results indicated Role of Salvia miltiorrhiza for Modulation of Th2-derived Cytokines in the Resolution of Inflammation
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Figure 2. ESM inhibited pro-inflammatory cyto-
kine production in LPS- stimulated RAW 264.7
cells. RAW 264.7 cells were treated with 
various concentrations (12.5, 25, 50, 100μg/ 
ml) in the absence or presence of LPS (100 
ng/ml) for 48 h. Culture supernatants were 
then collected and cytokine concentrations 
were measured using ELISA kits (A). RAW 
264.7 cells were incubated with ESM in the 
absence or presence of LPS for 24 h. Total 
RNA was isolated, and mRNA levels of each 
cytokine were then measured by RT-PCR (B). 
Cell lysates were extracted, and protein levels
of each cytokine were then analyzed by 
Western blotting (C). Each value represents the
mean ±S.D. in triplicate. 
††p＜0.01 vs. cells 
only based on a Student’s t-test. *p＜0.05, **p
＜0.01 vs. LPS only based on a Student’s t-test.Role of Salvia miltiorrhiza for Modulation of Th2-derived Cytokines in the Resolution of Inflammation
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that macrophages did not release NO in response to the me-
dium alone; LPS (100 ng/ml) was used as a positive control 
for macrophage activation. Further, ESM was found to inhibit 
NO production in a dose-dependent manner (Fig. 1A). Also, 
we determined the effect of ESM on PGE2 production from 
LPS-stimulated RAW 264.7 cells. LPS alone was able to mark-
edly induce cellular PGE2 production compared to controls. 
ESM decreased the level of PGE2 production from LPS-stimu-
lated RAW 264.7 cells in a dose-dependent manner (Fig. 1B). 
ESM also suppressed  the mRNA expression and  protein in-
duction  of  iNOS  and  COX-2  in  LPS-  stimulated  RAW  264.7 
cells (Fig. 1C and D). These results suggest that ESM attenu-
ated NO and PGE2 production at the gene and protein levels 
in  activated  macrophages.
ESM inhibited expression of pro-inflammatory cyto-
kines in LPS-stimulated murine macrophages 
We then investigated whether ESM inhibited the production 
of the pro-inflammatory cytokines, IL-1β, IL-6, and TNF-α 
in LPS-stimulated RAW 264.7 cells. Results indicated that ESM 
significantly inhibited the production of IL-1β, IL-6, and TNF-
α (Fig. 2A). ESM also attenuated their gene expressions and 
protein induction (Fig. 2B and C). These results suggest that 
ESM effectively inhibits pro-inflammatory cytokine production 
through the regulation of gene expression and protein activity 
of  IL-1β,  IL-6,  and  TNF-α in  activated  macrophages.
ESM down-regulated chemokine production in LPS- 
stimulated RAW 264.7 cells 
Next, we investigated whether ESM inhibited the production 
of chemokines such as RANTES and CX3CL1 and its receptor, 
CX3CR1,  and  inflammatory  mediators  like  TLR-4  and  11β- 
HSD1. Results demonstrated that ESM significantly decreased 
the  gene  expression  of  RANTES,  CX3CL1,  CX3CR1,  TLR-4, 
and 11β-HSD1 (Fig. 3), suggesting that ESM effectively in-
hibits  of  chemokine  production  through  the  regulation  of 
transcription of RANTES, CX3CL1, CX3CR1, TLR-4 and 11β- 
HSD1  in  activated  macrophages.
ESM increased Th2 cytokine production in LPS- 
stimulated RAW 264.7 cells 
W e  a l s o  i n v e s t i g a t e d  w h e t h e r  E S M  i n d u c e s  t h e  p r o t e i n  e x -
pression of Th2 cytokines such as IL-4, IL-10, and TGF-β. 
Th2  cytokines  are  considered  anti-inflammatory.  ESM  en-
hanced  the  protein  expression  of  IL-4  and  IL-10,  and  gene 
induction of IL-10, TGF-β, and IL-1Ra in a dose dependent 
manner (Fig. 4). These results suggest that ESM increases the 
productions of anti-inflammatory cytokines through the regu-
lation of  transcription of  IL-4, IL-10,  TGF-β,  and  IL-1Ra  in 
activated  macrophages.
Effect of ESM on the surface expression level of 
co-stimulatory molecules 
RAW 264.7 cell surface expression of ICAM-1, B7-1, and B7- 
2 was examined by flow cytometry. As shown in Fig. 5, there 
w e r e  n o  s i g n i f i c a n t  d i f f e r e n c e s  i n  t h e  e f f e c t  o f  E S M  o n  
ICAM-1,  B7-1,  or  B7-2.
DISCUSSION
Natural products have played a significant role in drug discov-
ery and development, especially against several well-known 
diseases.  Salvia  miltiorrhiza  has  frequently  been  used  in 
Chinese medicine as an anti-inflammatory and anti-allergenic 
agent. A tanshinone derivative was isolated as a major con-
stituent and some of its anti-inflammatory activities were pre-
viously described (16-18). Based on this study, we examined 
the effects of an ethanol extract of Salvia miltiorrhiza (ESM) 
on  pro-inflammatory  mediators  in  LPS-  induced  murine 
macrophages.  First,  we  evaluated  the  cytotoxicity  of  ESM 
(12.5∼100μg/ml) in RAW 264.7 cells, the results of which 
indicated that the tested concentrations of ESM did not affect 
cell  viability  (data  not  shown).  Therefore,  the  inhibition  of 
LPS-induced NO production by ESM was not the result of a 
cytotoxic  effect  on  these  cells.
    It has been previously reported that overproduction of in-
flammatory mediators contributes to the pathogenesis of sev-
eral  diseases  such  as  rheumatoid  arthritis,  chronic  in-
flammation,  and  autoimmune  diseases.  These  mediators in-
clude numerous chemokines, such RANTES and CX3CL1, and 
cytokines such TNF-α, IL-1β, and IL-6 (19). Chemokines are 
a  group  of  chemotactic  cytokines  that  induce  cellular  loco-
motion. The rapid production of chemokines at sites of in-
fection leads to the generation of a chemoattractant gradient 
that enables proper navigation and homing of effector cells 
(20). RANTES has been reported to attract and activate im-
mune cells and increases in RANTES expression have been 
associated with a wide range of inflammatory disorders and 
pathologies, including allogeneic transplant rejection, athero-
sclerosis, arthritis, and inflammatory airway disorders (21). In 
all of these pathologies, RANTES has been suggested to act 
by  promoting  leukocyte  infiltration  to  sites  of  inflammation Role of Salvia miltiorrhiza for Modulation of Th2-derived Cytokines in the Resolution of Inflammation
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Figure 3. ESM inhibited chemokine production in LPS- stimulated RAW 264.7 cells. RAW 264.7 cells were treated with various concentrations 
(12.5, 25, 50, 100μg/ml) in the absence or presence of LPS (100 ng/ml) for 24h. Cell lysates were extracted, and protein levels of each chemokine
were then analyzed by RT-PCR. Each value represents the mean±S.D. in triplicate. 
††p＜0.01 vs. cells only based on a Student’s t-test. *p＜0.05,
**p＜0.01 vs. LPS only based on a Student’s t-test.
(22). Another chemokine, CX3CL1 is a unique member of the 
CX3C  chemokine  subfamily,  with  each  member  mediating 
distinct biological effects (23). Both chemotaxis and adhesion 
have been shown to be mediated through the G-protein cou-
pled receptor CX3CR1. Accumulating evidence indicates that 
CX3CL1/CX3CR1 are involved in the pathogenesis of several 
inflammatory disorders such as glomerulonephritis, rheuma-
toid arthritis, and systemic lupuserythematosus (24,25). Fur-
thermore, RANTES and CX3CL1 play an important role in the 
pathogenesis of inflammatory diseases (26-28). In our results, 
ESM inhibited gene expression of chemokines such as RAN-
TES,  CX3CL1,  and  CX3CR1  (Fig  3A).
  Pro-inflammatory cytokines including TNF-α, IL-1β, and 
IL-6  are  present  in  large  quantities  in  inflammatory  tissues. Role of Salvia miltiorrhiza for Modulation of Th2-derived Cytokines in the Resolution of Inflammation
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Figure 4. ESM increased Th2 cytokine production in LPS- stimulated RAW 264.7 cells. RAW 264.7 cells were treated with various concentrations
(12.5, 25, 50, 100 μg/ml) in the absence or presence of LPS (100 ng/ml) for 24 h. Total RNA was isolated, and mRNA levels of each cytokine
were then measured by RT-PCR (A). Cell lysates were extracted, and protein levels of each cytokine were then analyzed by Western blotting 
(B). Each value represents the mean±S.D. in triplicate. 
†p＜0.05, 
††p＜0.01 vs. cells only based on a student’s t-test. *p＜0.05, **p＜0.01 
vs. LPS only based on a student’s t-test.
They have been demonstrated to be continuously produced 
and  to  be  responsible  for  aggravating  inflammation  (29). 
Prostaglandin  E2 a n d  N O  a r e  i m p o r t a n t  f o r  m a i n t a i n i n g  i n -
flammatory conditions, and COX-2 and iNOS, which are ex-
pressed by inflammatory signals, are the enzymes responsible 
for producing large amounts of PGE2 and NO. Excessive pro-
duction of these  inflammatory mediators  has  been detected 
in  septic  and  hemorrhagic  shock,  rheumatoid  arthritis,  and 
atherosclerosis [4]. According to our results, ESM suppressed 
the production of NO, PGE2, TNF-α, IL-1β, and IL-6 through 
a decrease in the gene and protein levels of iNOS, COX-2, 
TNF-α, IL-1β, and IL-6 in LPS-stimulated RAW 264.7 cells 
(Figs.1  and  2).
  1 1 β-Hydroxysteroid dehydrogenase type 1 (11β-HSD1) is 
an  intracellular  amplifier  of  glucocorticoids.  Glucocorticoids 
are hormones that regulate a variety of homeostatic processes Role of Salvia miltiorrhiza for Modulation of Th2-derived Cytokines in the Resolution of Inflammation
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including  metabolism,  cell  proliferation  and  differentiation, 
and immune functions including inflammation (30). Toll-like 
receptors  (TLRs)  including TLR1, 2, 4, 5, 6, 7, and 9, play 
a  crucial  role  in  host  defense  against  invading  micro-
organisms. In particular, TLR4 was identified as a signal trans-
ducer for LPS, a major cell wall component of Gram-negative 
bacteria (31). TLR4 signaling led to the induction of pro-in-
flammatory cytokines through activation of NF-κB. In our re-
sults, ESM decreased the expression of inflammatory media-
tors  such  as  11β-HSD1  and  TLR4  (Fig.  3B).
    The  most  powerful  regulatory  components  are  anti-in-
flammatory cytokines such as IL-4, IL-10, IL-1Ra, and TGF-β. 
These  cytokines  either  provide  insufficient  control  over 
pro-inflammatory activities resulting in immune-mediated dis-
ease  or  they  overcompensate  and  inhibit  the  immune  re-
sponse, rendering the host at risk of systemic infection (1). 
CD4
＋  helper  cells  have  been  classified  as  Th1/2-type  cells 
based on the production of specific cytokines (32). The Th2- 
type  cells  were  reported  to  produce  a  variety  of  anti-in-
flammatory  cytokines,  including  IL-4,  IL-5,  and  IL-10  (33). 
These cells derived from IL-4 and IL-10, have been reported 
to lead to the suppression of Th1 responses by down-regulat-
ing the production of macrophages derived from IL-12 and 
inhibiting the differentiation of Th1-type cells (34). Further-
more, IL-4 has been shown to have marked inhibitory effects 
on the expression and release to pro-inflammatory cytokines. 
Additionally, IL-1Ra is known to block the action of IL-1α 
and IL-1β functional ligands through competitive inhibition 
at the IL-1 receptor level and TGF-β has been reported to 
be an important regulator of cell proliferation, differentiation, 
and formulation of the extracellular matrix. All of these are 
in  clinical  trials  as  anti-inflammatory  therapies  for  inflam-
matory disease (1). Accordingly, in the current study, the an-
ti-inflammatory effect of ESM in activated RAW 264.7 cells in-
volved the production of anti-inflammatory cytokines includ-
ing  IL-4,  IL-10,  TGF-β,  and  IL-1Ra  (Fig.  4).
　The  intracellular  adhesion  molecules  (ICAMs),  ICAM-1, 
ICAM-2 and ICAM-3, are cell surface ligands for the leukocyte 
integrins. They are crucial in the binding of lymphocytes and 
other leukocytes to certain cells including antigen-presenting 
cells (APCs). The B7 family plays important role as co-stim-
ulatory factors of APCs (35). In addition, CD24 combines with 
Figure 5. Effects of ESM on the surface expression levels of 
co-stimulatory molecules. RAW 264.7 cells were cultured and acti-
vated with LPS (100 ng/ml) in absence or presence of various ESM
concentrations for 24 h. The surface (A) ICAM-1, (B) B7-1, and (C)
B7-2 were labeled with either anti-ICAM-1 or anti-B7-1/-2 and the 
cells were then stained using anti-Vβ8.1＋8.2-FITC, anti-Vβ2-PE, or
anti-Vβ2-FITC, which served as an isotype control for nonspecific 
binding.Role of Salvia miltiorrhiza for Modulation of Th2-derived Cytokines in the Resolution of Inflammation
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t h e  B 7  f a m i l y  t o  a i d  A P C s .  B a s e d  o n  o u r  r e s u l t s ,  E S M  d i d 
not exhibit significant effects on any of the molecules includ-
ing ICAM-1, B7- 1, and B7- 2 (Fig. 5). Although the role of 
co-stimulatory  factors  is  important  with  regard  to  the  in-
flammatory reaction, the results here suggest that ESM has an-
ti-inflammatory  effects  without  affecting  the  expression  of 
ICAMs. In an additional study, ESM did not show significant 
effects  on  co-stimulatory  molecules  with  regard  to  whether 
different  pathways  could  be  regulated  by  T-cells.
　In this study, we have demonstrated that ESM inhibits the 
production of NO, PGE2, IL-1β, IL-6, and TNF-α, and the 
expression  of  RANTES,  CX3CL1,  CX3CR1,  11β-HSD1,  and 
TLR4,  whereas  it  enhances  the  production  of  anti-inflam-
matory cytokines including IL-4, IL-10, TGF-β, and IL-1Ra in 
LPS-stimulated  macrophages.  Thus,  we  conclude  that  ESM 
represents  a  potentially  significant  therapeutic  drug  for  the 
treatment  of  inflammatory  disease.
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